Issue 3/2021
Content (10 Articles)
Clinical Pharmacokinetics of Daptomycin
Nicolas Gregoire, Alexia Chauzy, Julien Buyck, Blandine Rammaert, William Couet, Sandrine Marchand
Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib
Olivia Campagne, Kee Kiat Yeo, Jason Fangusaro, Clinton F. Stewart
Population Pharmacokinetics of Levetiracetam: A Systematic Review
Zi-ran Li, Chen-yu Wang, Xiao Zhu, Zheng Jiao
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight
Dinko Rekić, Susanne Johansson, Jacob Leander
Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation
Georgios Schoretsanitis, Maxim Kuzin, John M. Kane, Christoph Hiemke, Michael Paulzen, Ekkehard Haen
Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers
Michael Boettcher, Stephanie Loewen, Mireille Gerrits, Corina Becker
Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients
L. B. S. Aulin, P. De Paepe, E. Dhont, A. de Jaeger, J. Vande Walle, W. Vandenberghe, B. C. McWhinney, J. P. J. Ungerer, J. G. C. van Hasselt, P. A. J. G. De Cock
Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, Nader Najafian, Jae Kim, Valerie A. Clausen, Varun Goel, Bahru Habtemariam, Gabriel J. Robbie
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV
Perrine Courlet, Monia Guidi, Susana Alves Saldanha, Felix Stader, Anna Traytel, Matthias Cavassini, Marcel Stoeckle, Thierry Buclin, Catia Marzolini, Laurent A. Decosterd, Chantal Csajka
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
Arthur Lo, Marie T. Borin, David L. Bourdet